• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment

cafead

Administrator
Staff member
  • cafead   Aug 29, 2024 at 11:12: AM
via
  • Artiva has two-bagger potential in the eyes of multiple Wall Street analysts.
  • Its cell therapies could provide a much more efficient treatment of autoimmune diseases.
  • Artiva faces years of hurdles, but investors could make out handsomely if it is successful.

article source
 

<